Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
A Randomized, Double-blind, Parallel-group, Multicenter Study to Demonstrate Similar Efficacy and to Compare Safety and Immunogenicity of GP2017 and Humira® in Patients With Moderate to Severe Active Rheumatoid Arthritis A Randomized, Double-blind, Parallel-group, Multicenter Study to Demonstrate Similar Efficacy and to ...
Rheumatoid Arthritis
Biological: Adalimumab - GP2017;Biological: Adalimumab - US licensed Humira
Sandoz
Hexal AG
Completed
18 Years
N/A
All
353
Phase 3
United States;Czechia;Germany;Hungary;Italy;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;United Kingdom;Czech Republic United States;Czechia;Germany;Hungary;Italy;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia ...